SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-23-010145
Filing Date
2023-03-31
Accepted
2023-03-31 16:03:40
Documents
68
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K blcm-20221231.htm   iXBRL 10-K 1414202
2 EX-4.6 exhibit46-descriptionofcom.htm EX-4.6 33788
3 EX-10.5(A) exhibit105a-2019equityince.htm EX-10.5(A) 227232
4 EX-21.1 exhibit211subsidiaries2022.htm EX-21.1 2166
5 EX-23.1 exhibit231consentofey2022.htm EX-23.1 4120
6 EX-31.1 exhibit311-202210k.htm EX-31.1 9150
7 EX-32.1 exhibit321-202210k.htm EX-32.1 5650
  Complete submission text file 0001628280-23-010145.txt   7263203

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20221231.xsd EX-101.SCH 49766
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blcm-20221231_cal.xml EX-101.CAL 58755
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20221231_def.xml EX-101.DEF 269945
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20221231_lab.xml EX-101.LAB 656092
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20221231_pre.xml EX-101.PRE 427996
62 EXTRACTED XBRL INSTANCE DOCUMENT blcm-20221231_htm.xml XML 934193
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36783 | Film No.: 23787466
SIC: 2834 Pharmaceutical Preparations